Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000514093 | SCV000609543 | uncertain significance | not provided | 2017-05-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000623865 | SCV000740789 | uncertain significance | Inborn genetic diseases | 2015-01-14 | criteria provided, single submitter | clinical testing | Lines of evidence used in support of classification: UNCERTAIN: Alteration(s) of Uncertain Clinical Significance Detected |
Labcorp Genetics |
RCV000699009 | SCV000827702 | benign | Charcot-Marie-Tooth Neuropathy X; Combined oxidative phosphorylation deficiency | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000766070 | SCV000897542 | uncertain significance | Charcot-Marie-Tooth disease X-linked recessive 4; Deafness, X-linked 5; Severe X-linked mitochondrial encephalomyopathy | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000514093 | SCV002504284 | likely benign | not provided | 2020-03-04 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Mayo Clinic Laboratories, |
RCV000514093 | SCV002541764 | uncertain significance | not provided | 2021-12-23 | criteria provided, single submitter | clinical testing |